PubMed Health⌕ Search

Biomedical subjects

R Daelemans

Publications and source records attributed to R Daelemans.

44 records · Page 3Linked to original sources
PubMed1987

Paraneoplastic Sjögren's syndrome.

A patient with primary Sjögren's syndrome preceding an oat cell carcinoma of the lung, is presented. Arguments to support a possible relationship between these two disorders are discussed.

Carcinoma, Small Cell↗
PubMed1987

Acute oligo-anuria during ovarian hyperstimulation syndrome.

Severe ovarian hyperstimulation developed in a young woman during ovulation induction with human menopausal and chorionic gonadotropins. This was complicated by acute functional renal insufficiency with vascular overfilling and incipient pulmonary edema, possibly caused by indomethacine and fluid treatment. The pathogenetic mechanisms involved are discussed.

Acute Kidney Injury↗
PubMed1984

Pacemaker endocarditis: contribution of two-dimensional echocardiography.

A case of pacemaker endocarditis is presented. Electrode vegetations could be diagnosed by two-dimensional echocardiography. Prolonged antibiotic therapy failed. Only when the entire pacing system had been removed by cardiotomy with cardiopulmonary bypass, the infection cleared.

Echocardiography↗
PubMed1983

Scopolamine intoxications.

Pure scopolamine intoxications are extremely rare. We treated a series of severe intoxications exclusively caused by scopolamine and due to the intentional mixing of pure scopolamine into drinks. The clinical course and therapy are reported. On the basis of our experience and a survey of literature, we found physostigmine to be an excellent antidote. The symptomatology of the patients confirms that scopolamine has a dose-related stimulant effect on the central nervous system.

Adult↗
PubMedDate not supplied

Hypertension and accelerated atherosclerosis in endstage renal disease.

In patients with chronic renal failure cardiovascular morbidity and mortality are higher than in non-uremic controls. Chronic renal failure influences a number of factors that promote atherogenesis: blood pressure, nitric oxide activity, advanced glycosylation, lipid metabolism, oxidant stress, homocysteine levels, glucose metabolism and PTH. How these factors are influenced by chronic renal failure, how they interrelate and how they promote atherogenesis is still debated. Published data are for and against accelerated atherogenesis. The use of only clinical endpoints may be partially responsible for these conflicting data. Measurement of atherosclerosis itself by computerized ultrasound imaging of the common carotid arteries can be used as an outcome variable. We conclude that there is still a need for prospective, controlled, epidemiologic studies to answer the question whether or not atherogenesis is accelerated in chronic renal failure and to clarify the role of hypertension and other risk factors.

Animals↗